Anglo Asian Mining Share Discussion Threads

[avsome1968] 04/6/2020 08:31

Will be hanging on to MPH least they've got funding in uncertain times not a bad news to me.

[bumpa33] 04/6/2020 08:29

Mr R Ditto - when I saw the auction process I thought if I can get out even I’ll take it. Just don’t like situations I don’t understand. On the plus side should be (!) fully funded now and potential pipeline developments sound very good.

[mr roper] 04/6/2020 08:24

Bumpa, it’s holding up well. Suspect it may come good, I’ll keep an eye out but happier out than in at the moment

[bumpa33] 04/6/2020 08:20

Disappointing Mr R - May well still come good but I’m not comfortable with the CLN’s, was a bit lucky there were bids in the auction at 24 down, paid 0.5 to the mm who executed it.

[riggerbeautz] 04/6/2020 08:18

Sat on the sidelines, with brew in hand, watching all the usual AIM stuff happening, I’m going to go look at the fields at Newmarket today, might as well gamble on something I enjoy, than the casino that is AIM lol

[bumpa33] 04/6/2020 08:17

Hearing AVCT is 5 times oversubscribed....

[mr roper] 04/6/2020 08:15

Added Plus on the back of the IG update

[mr roper] 04/6/2020 08:14

Out Mph as well, bumpa.

[jbe81] 04/6/2020 08:13

Jeansey re ODX, I believe the supply is coming from shares gifted to charity hence the fall in share price It also falls every morning followed by a recovery during the day. From the news I see it as a low risk play unless the market revalues covid plays. So short term I can see it a lot higher

[donald pond] 04/6/2020 08:12

I've bought some XPP this morning. Solid, profitable company but issued a great trading update - orders have gone through the roof this year, revenue yet to drop though. Should be at all time highs soon

[callmebwana] 04/6/2020 08:09

I won't be putting anything in there.
It is AIM and insider dealing and the pigs have their snouts in the trough!!
My current holding is free as I took my investments in AVCT out, I posted when I did that.
Compare AAZ BoD to that of these companies,chees and chalk comes to mind.
ATB.

[bumpa33] 04/6/2020 08:03

Out MPH even in the auction @ 23. Neither I or broker understand the CLN conversion details so won’t be going here again. Good luck.

[sportbilly1976] 04/6/2020 07:56

Re AVCT:

a) The Retail Offer - Retail investors
An offer of New Ordinary Shares at the Issue Price (the "Retail Offer"), with a minimum subscription of GBP100 per investor, is open to retail investors subscribing via PrimaryBid.com. The Retail Offer will not raise more than EUR8 million equivalent

Let's see how many manage to get some of that £8mln

[kickingking] 04/6/2020 07:55

Good morning. Who said this management is not to be trusted. It nice they awarded them self option at between 10p to 17p. I will not participate in fundraise. I want my shares in an ISA, with primarybid they can not do that. Too much insider knowledge. Someone on AVCT board was saying there will bid a fundraising this morning at almost identical price. They probably work for primarybid. Anyway it puts a Base price. So we should here more news tomorrow or early next week. GLA.

[wanobi] 04/6/2020 07:45

indeed I can cmb, indeed I can,,,, great spot Bumpa and many many thanx for sharing your hunch with us all :-) Cheers Wan :-)

[callmebwana] 04/6/2020 07:43

Wan,can you see the advantage of having a professional trader on this thread ?

Bumpa, a very good call by you again Sir
LOL, AIM investing at it's best !!

[pogue] 04/6/2020 07:30

wow that was a rush
Got on the AVCT placing good luck if you are about to try




Avacta Group plc (AIM: AVCT) , the developer of Affimer(R) biotherapeutics and reagents, announces offers for subscription via PrimaryBid of new ordinary shares of 10p each in the Company ("New Ordinary Shares") at an issue price of 120 pence per New Ordinary Share (the "Issue Price"), being a discount of 4.4 per cent to the 30 day volume weighted average price of the Company's ordinary shares on the AIM market of London Stock Exchange plc ("AIM " ) on 3 June 2020, being 125.3 pence per Ordinary Share.
The Company is also conducting a non-pre-emptive placing of new Ordinary Shares at the Issue Price (the "Placing Shares") by way of an accelerated bookbuild process being carried out by finnCap Ltd (acting as nominated adviser), and finnCap Ltd, Zeus Capital Limited and Beech Hill Securities, Inc. acting as joint brokers (together, the "Joint Brokers") (the "Placing") and a subscription of new Ordinary Shares at the Issue Price (the "Subscription Shares") (the "Subscription"), each as announced earlier today.
The Placing and the Subscription have been split into two tranches, the first placing of up to 24,400,079 Placing Shares (the "First Placing") and the first subscription of up to 2,005,451 Subscription Shares (the "First Subscription"), with admission of such shares to trading on the AIM expected to become effective at 8.00 a.m. on or about 10 June 2020 (or such later date and/or time as the Joint Brokers and the Company may agree, being no later than 8.00 a.m. on 10 July 2020).
The second tranche of the Placing and the Subscription, being of up to a further 7,324,266 Placing Shares (the "Second Placing") and of up to a further 914,215 Subscription Shares (the "Second Subscription") is conditional upon, amongst other things, (i) the passing of the relevant resolution(s) of the Company's shareholders at a general meeting to be convened pursuant to a notice of general meeting to form part of a circular to shareholders expected to be published during the week commencing 8 June 2020 and (ii) admission of such shares to trading on the AIM (which is expected to be take place on or about 25 June 2020 (but in any event no later than 8.00 a.m. on 10 July 2020)).
2. PrimaryBid Offers
The Company values highly its retail investor base which has supported the Company alongside institutional investors over several years. Given the longstanding support of retail shareholders, the Company believes that it is appropriate to provide retail and other interested investors the opportunity to participate in the PrimaryBid Offers (as defined below). The Company is therefore making the PrimaryBid Offers available exclusively through PrimaryBid.com a nd the PrimaryBid mobile app available on the Apple App Store and Google Play. PrimaryBid does not charge investors any commission for this service.
The offers for subscription via PrimaryBid are divided into two separate offers, one to retail investors and the second to "qualified investors" within the meaning of the EU's Prospectus Regulation (Regulation (EU) 2017/1129) (the " Prospectus Regulation ") (together, the "PrimaryBid Offers").
The Company, in consultation with PrimaryBid, reserves the right to scale back any order under the PrimaryBid Offers at its absolute discretion subject to conditions which are available to view on PrimaryBid.com . The Company currently expects that preference will be given to the Company's existing investors.
The PrimaryBid Offers are offered under the prospectus exemptions applicable pursuant to the Prospectus Regulation and the FCA's Prospectus Regulation Rules. As such, there is no need for publication of a prospectus in connection with either of the PrimaryBid Offers . The separate PrimaryBid Offers are:
(a) The Retail Offer - Retail investors
An offer of New Ordinary Shares at the Issue Price (the "Retail Offer"), with a minimum subscription of GBP100 per investor, is open to retail investors subscribing via PrimaryBid.com. The Retail Offer will not raise more than EUR8 million equivalent.
(b) The Qualified Investor Offer - Institutional investors or others
A separate offer is available to institutional investors (the "Qualified Investor Offer") who are "qualified investors" within the meaning of Article 2(e) of the Prospectus Regulation (the "Qualified Investors"). Those applications will automatically be allocated to the Qualified Investor Offer.
The PrimaryBid Offers, the Second Placing and the Second Subscription are each conditional upon, amongst other things, (i) the new Ordinary Shares to be issued pursuant to the PrimaryBid Offers, the Second Placing and the Second Subscription being admitted to trading on AIM ( " Second Admission " ). Second Admission is expected to be take place at 8.00 a.m. on 25 June 2020 (but in any event no later than 8.00 a.m. on 10 July 2020); and (ii) the placing agreement entered into between the Company and the Joint Brokers in connection with the Placing not being terminated in accordance with its terms prior to Second Admission .
The PrimaryBid Offers, via the PrimaryBid.com platform, will be open to individual and institutional investors from 7.01 a.m. on 4 June 2020 to 4.30 p.m. on 4 June 2020. The PrimaryBid Offers may close early if they are oversubscribed. Once an application for New Ordinary Shares has been made and accepted via PrimaryBid, an application cannot be withdrawn.
The terms and conditions on which the PrimaryBid Offers are made, including the procedure for application and payment for New Ordinary Shares, are available to all persons who register with PrimaryBid.com. For further information on the PrimaryBid Offers visit www.PrimaryBid.com or call PrimaryBid.com on [phone].
The New Ordinary Shares will be issued free of all liens, charges and encumbrances and will, when issued and fully paid, rank pari passu in all respects with the Company's then existing Ordinary Shares.
3. Use of proceeds
The Company will use the funds raised pursuant to the Placing, Subscription and PrimaryBid Offers, amongst other things, to accelerate the scale-up of the broader Affimer(R) diagnostic products opportunities, including COVID-19 antigen rapid testing and expansion of the in-house diagnostics product development capabilities .

[droyden] 04/6/2020 07:27

Excellent call Bumpa

[bumpa33] 04/6/2020 07:24

bloody hell, placings everywhere...

[wanobi] 04/6/2020 07:24

AVCT - so, now, the $64,000 question,,, with news of the Cytiva Atigen Test surely imminent, funding sorted for the foreseeable,,, is it time to buy again!!??

Will they get the test working!!!

We still have NO view of the deal in terms of revenue to AVCT!!!

GLA Holders, Cheers Wan :-)

[wanobi] 04/6/2020 07:20

PUR - Pure Gold Mining Inc. Drilling Recommences at the PureGold Red Lake Mine

Cheers
Wan :-)

[wanobi] 04/6/2020 07:18

ORPH - Launch of Covid-19 Antibody Testing

Open Orphan plc (ORPH), a rapidly growing specialist CRO pharmaceutical services company which is the world leader in the testing of vaccines and antivirals using human challenge study models, announces the launch of hVIVO COVID Clear Test, the Company's antibody testing service, following the successful completion of installation, testing and training.

The antibody tests, which utilise the Quotient MosaiQ(TM) system and MosaiQ COVID-19 Antibody Microarray, offer best in class COVID-19 antibody testing performance and will require a full blood draw. hVIVO COVID Clear Test will be offered to large employer groups and channel partners including GP networks, nursing services, health clinics and private hospitals. Samples will be tested in the Company's London laboratory with results returned within 48 hours.

Cheers
Wan :-)

[wanobi] 04/6/2020 07:15

Yep, all credit to Bumpa & 2P,,, well spotted guys :-) Cheers Wan :-)

GAP may get filled today then :-)


free stock charts from uk.advfn.com


Avacta Group plc (AIM: AVCT), the developer of Affimer(R) biotherapeutics and reagents , announces in response to substantial institutional interest, its intention to raise gross proceeds of up to GBP45 million by means of a placing to institutional and other investors (the "Placing"), a direct subscription with the Company (the "Subscription") and offers to retail and other investors via the PrimaryBid platform (the "PrimaryBid Offers") (the PrimaryBid Offers, the Placing and the Subscription together being the "Fundraising"), of up to 37,500,000 new ordinary shares of 10 pence each in the Company (the "New Ordinary Shares"), in each case at a price of 120 pence per share ("Issue Price").

The Issue Price is at a discount of approximately 4.4 per cent to the 30 day volume weighted average price of the Ordinary Shares on AIM on 3 June 2020 , being 125.3 pence per Ordinary Share.

[2prsimo] 04/6/2020 07:10

Good call Bumpa - again!